ICON Public Limited Company

ICON Public Limited Company Q3 2026 Earnings Recap

ICLR Q3 2026 Published November 1, 2026

Get alerts when ICLR reports next quarter

Set up alerts — free

ICON shares rose 17.8% after the company reported record net business wins and sequential improvement in gross margin, adjusted EBITDA, and EPS. Management said Q3 results were in line with its expectations, while the transcript provides no market-consensus comparison.

Earnings Per Share Beat
$2.66 vs $2.62 est.
+1.5% surprise
Revenue Beat
2024757000 vs 2012548000 est.
+0.6% surprise

Market Reaction

Post-Earnings +17.76%
Nov 2 to Nov 9 +1.19%

See ICLR alongside your other holdings

Add to your portfolio — free

Key Takeaways

  • Net business wins reached a record $3.15 billion, up 51% year over year; net book-to-bill was 1.56x, the fourth consecutive quarter above 1.3x.
  • Gross margin improved 90 basis points sequentially. Adjusted EBITDA was $337 million, and adjusted EPS of $2.66 was up 4% from Q2.
  • Free cash flow was $300 million; ICON repurchased $400 million of shares and ended the quarter with $800 million in cash.
  • Commercial momentum included large-pharma strength, new and expanded midsized partnerships, and three preferred biotech partnerships.
  • Technology-enabled execution showed measurable gains: in-scope SDTM programming cycle times fell 28%, while study-startup throughput rose about 30% year to date.
This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit ICLR on AllInvestView.

Get the Full Picture on ICLR

Track ICON Public Limited Company in your portfolio with real-time analytics, dividend tracking, and more.

View ICLR Analysis